dc.contributor.author | ERTEN, Sebile Nilgün | |
dc.contributor.author | Sutcu, Recep | |
dc.contributor.author | DEMİRCİ, Serpil | |
dc.date.accessioned | 2022-02-18T11:01:16Z | |
dc.date.available | 2022-02-18T11:01:16Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | ERTEN S. N. , DEMİRCİ S., Sutcu R., "Prevalence of Thrombophilic Mutations in Ischemic Stroke Patients in Isparta, Turkey", TURKISH JOURNAL OF NEUROLOGY, cilt.21, sa.2, ss.42-48, 2015 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_cf9a298b-b1f1-4273-8da5-faf75f040a69 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/180343 | |
dc.identifier.uri | https://doi.org/10.4274/tnd.37880 | |
dc.description.abstract | Objective: The present study aimed to investigate whether the frequency of factor V, methylenetetrahydrofolate reductase (MTHFR), prothrombin, beta-fibrinogen gene mutations, and human platelet alloantigens (HPA), plasminogen activator inhibitor 1 (PAI1), apolipoprotein E (APOE), and angiotensin converting enzyme (ACE) gene polymorphisms in stroke patients is higher than that in normal individuals. | |
dc.language.iso | eng | |
dc.subject | Neurology | |
dc.subject | Neurology (clinical) | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Prevalence of Thrombophilic Mutations in Ischemic Stroke Patients in Isparta, Turkey | |
dc.type | Makale | |
dc.relation.journal | TURKISH JOURNAL OF NEUROLOGY | |
dc.contributor.department | Giresun Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
dc.identifier.volume | 21 | |
dc.identifier.issue | 2 | |
dc.identifier.startpage | 42 | |
dc.identifier.endpage | 48 | |
dc.contributor.firstauthorID | 3382742 | |